Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:25:40.995Z.
Calculation as of: 2026-10-06T13:25:40.995Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ade6551c806a0b8a23cc3b9f653dfce73cf5104c20f92b5c51aa4b81f5201f45
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
BlossomHill Therapeutics, Inc.
Market Cap
$579.88M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$573.38M
Free Cash Flow Yield
N/A
TTM Avg
7.20%
3Y Avg
7.20%
5Y Avg
7.20%
Market Cap
$587.93M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$569.56M
Free Cash Flow Yield
43.94%
TTM Avg
19.72%
3Y Avg
17.48%
5Y Avg
17.48%
Market Cap
$596.36M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$561.67M
Free Cash Flow Yield
N/A
TTM Avg
3.48%
3Y Avg
3.86%
5Y Avg
13.58%
Market Cap
$600.84M
Free Cash Flow Yield
30.88%
TTM Avg
16.53%
3Y Avg
24.36%
5Y Avg
19.94%
Market Cap
$551.09M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$547.86M
Free Cash Flow Yield
3.20%
TTM Avg
3.62%
3Y Avg
3.23%
5Y Avg
3.23%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $579.88M | N/A | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | N/A | 7.20% | 7.20% | 7.20% |
| OrthoPediatrics Corp. (KIDS)vs › | $587.93M | N/A | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $569.56M | 43.94% | 19.72% | 17.48% | 17.48% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | N/A | 3.48% | 3.86% | 13.58% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 30.88% | 16.53% | 24.36% | 19.94% |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | 3.20% | 3.62% | 3.23% | 3.23% |
| Climb Bio, Inc. (CLYM)vs › | $632.76M | N/A | 0.02% | 0.02% | 0.02% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
